SCHEMBL13315659

SCHEMBL13315659

Cc1ncccc1C(=O)N[C@@H](C)CN1CC(C)(C)OCC1C(=O)Nc1cc(Cl)cc2c1[nH]c1cnccc12

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ICOSLG O75144 13/20 0.53
ICOS Q9Y6W8 13/20 0.53
CHUK O15111 13/20 0.46
IKBKB O14920 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
PIM1 P11309 1/20 0.44
PIM3 Q86V86 1/20 0.44
IKBKG Q9Y6K9 1/20 0.44
TYK2 P29597 1/20 0.44
CLK1 P49759 1/20 0.44
CLK2 P49760 1/20 0.44
DYRK1A Q13627 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
PI4KB Q9UBF8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800039 1.00 ICOSLG (0.53) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL12653018 0.94 ICOSLG (0.52) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL1800498 0.94 ICOSLG (0.52) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL12619419 0.93 ICOSLG (0.52) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL1797470 0.93 ICOSLG (0.52) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL12619412 0.92 ICOSLG (0.53) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL1800472 0.91 ICOSLG (0.43) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL1799816 0.91 ICOSLG (0.56) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL13315672 0.91 ICOSLG (0.56) ICOSLGICOSCHUKIKBKBKMT2A
SCHEMBL1803266 0.90 ICOSLG (0.42) ICOSLGICOSCHUKIKBKBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727985-B2 Beta-carbolines useful for treating inflammatory disease MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
US-7727985-B2 Beta-carbolines useful for treating inflammatory disease MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed